Predict

Predictive Oncology is a knowledge-driven biotechnology company focused on applying artificial intelligence to develop personalized cancer therapies and improve drug discovery. The company utilizes its proprietary PEDAL platform, which leverages a massive biobank of over 150,000 patient-derived tumor samples to predict how specific cancer types will respond to various drug compounds. By integrating multi-omic data with machine learning, Predictive Oncology aims to reduce the risk of clinical trial failure and accelerate the delivery of effective treatments to patients. Their business model encompasses internal drug development programs as well as strategic partnerships with pharmaceutical companies to optimize their pipelines.